These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Infection of baboons with simian/human immunodeficiency viruses. Allan JS, Ray P, Broussard S, Whitehead E, Hubbard G, Butler T, Brasky K, Luciw P, Cheng-Mayer C, Levy JA. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug 15; 9(5):429-41. PubMed ID: 7627620 [Abstract] [Full Text] [Related]
24. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function. Raja NU, Jabbar MA. Virology; 1996 Jun 01; 220(1):141-51. PubMed ID: 8659106 [Abstract] [Full Text] [Related]
26. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. Joag SV, Li Z, Foresman L, Stephens EB, Zhao LJ, Adany I, Pinson DM, McClure HM, Narayan O. J Virol; 1996 May 01; 70(5):3189-97. PubMed ID: 8627799 [Abstract] [Full Text] [Related]
27. Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time. Silverstein PS, Mackay GA, Mukherjee S, Li Z, Piatak M, Lifson JD, Narayan O, Kumar A. J Virol; 2000 Nov 01; 74(22):10489-97. PubMed ID: 11044093 [Abstract] [Full Text] [Related]
28. Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina). Chen Z, Huang Y, Zhao X, Skulsky E, Lin D, Ip J, Gettie A, Ho DD. J Virol; 2000 Jul 01; 74(14):6501-10. PubMed ID: 10864663 [Abstract] [Full Text] [Related]
29. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms. Korth MJ, Taylor MD, Katze MG. Virology; 1998 Aug 01; 247(2):265-73. PubMed ID: 9705919 [Abstract] [Full Text] [Related]
30. Initial characterization of viral sequences from a SHIV-inoculated pig-tailed macaque that developed AIDS. Stephens EB, Joag SV, Sheffer D, Liu ZQ, Zhao L, Mukherjee S, Foresman L, Adany I, Li Z, Pinson D, Narayan O. J Med Primatol; 1996 Jun 01; 25(3):175-85. PubMed ID: 8892038 [Abstract] [Full Text] [Related]
31. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease. McKenna PM, Koser ML, Carlson KR, Montefiori DC, Letvin NL, Papaneri AB, Pomerantz RJ, Dietzschold B, Silvera P, McGettigan JP, Schnell MJ. J Infect Dis; 2007 Apr 01; 195(7):980-8. PubMed ID: 17330788 [Abstract] [Full Text] [Related]
33. Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta. Bogers WM, Dubbes R, ten Haaft P, Niphuis H, Cheng-Mayer C, Stahl-Hennig C, Hunsmann G, Kuwata T, Hayami M, Jones S, Ranjbar S, Almond N, Stott J, Rosenwirth B, Heeney JL. Virology; 1997 Sep 15; 236(1):110-7. PubMed ID: 9299623 [Abstract] [Full Text] [Related]
34. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. Wildum S, Schindler M, Münch J, Kirchhoff F. J Virol; 2006 Aug 15; 80(16):8047-59. PubMed ID: 16873261 [Abstract] [Full Text] [Related]
35. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication. Kuwata T, Igarashi T, Ido E, Jin M, Mizuno A, Chen J, Hayami M. J Gen Virol; 1995 Sep 15; 76 ( Pt 9)():2181-91. PubMed ID: 7561755 [Abstract] [Full Text] [Related]
36. A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has a limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has offered cytotropism. Stephens EB, Mukherjee S, Sahni M, Zhuge W, Raghavan R, Singh DK, Leung K, Atkinson B, Li Z, Joag SV, Liu ZQ, Narayan O. Virology; 1997 May 12; 231(2):313-21. PubMed ID: 9168893 [Abstract] [Full Text] [Related]
37. The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. Bour S, Strebel K. J Virol; 1996 Dec 12; 70(12):8285-300. PubMed ID: 8970948 [Abstract] [Full Text] [Related]
38. Vpu: a multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1. Hout DR, Mulcahy ER, Pacyniak E, Gomez LM, Gomez ML, Stephens EB. Curr HIV Res; 2004 Jul 12; 2(3):255-70. PubMed ID: 15279589 [Abstract] [Full Text] [Related]
39. Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques. Noel RJ, Kumar A. Virology; 2006 Mar 01; 346(1):127-38. PubMed ID: 16313937 [Abstract] [Full Text] [Related]